20 February 1998 in Science
Studies of lymphocyte turnover in animal models have implications for understanding the mechanism of cell killing and the extent of lymphocyte regeneration in human immunodeficiency virus infection. Quantitative analyses of the sequential changes in bromodeoxyuridine labeling of CD4 and CD8 T lymphocytes not only revealed the normal proliferation and death rates of these cell populations in uninfected macaques, but also showed a substantial increase in these rates associated with simian immunodeficiency virus (SIV) infection. Faster labeling and delabeling in memory and naı̈ve T lymphocyte subpopulations as well as in NK (natural killer) and B cells were also observed in infected macaques, suggesting a state of generalized activation induced by SIV.
3 May 2016 in Cytometry Part A
Studying single cells reveals biology that cannot be explored using bulk techniques. Cell sorters provide the opportunity of separating single cells either for cell culture or for downstream molecular applications such as qPCR to study specific gene expression and single cell mRNA sequencing. Some of these molecular studies can be expensive so the investigator will often want reassurance that the cell sorter can reliably deposit a single droplet into each well of a 96‐well or 384‐well plate. Such plates may contain very small volumes of fluid as reducing the volume of fluid used can reduce the cost of the assay. To miss some of the wells could leave the data set incomplete requiring costly repetition. To verify this by microscopy is at best very time consuming and at worst impossible. Here, an inexpensive colorimetric method is described for verifying whether a well, in either a 96‐ or 384‐well plate, did receive a single sorted droplet from a cell sorter into the fluid at the bottom of the well. The droplet consists of particles suspended in an enzymatic solution, horseradish peroxidase, which is deposited into microtiter plate wells containing a substrate, 3,3′,5,5′‐tetramethylbenzidine. This method requires no special equipment or expertise and is rapid enough to be performed directly prior to the single‐cell sorting experiment. © 2016 International Society for Advancement of Cytometry
1 January 1996 in Cytogenetic and Genome Research
Centromere activation, an important mechanism in karyotype evolution, is occasionally observed in some human chromosome rearrangements. We report a possible occurrence of centromere activation in a marker chromosome containing an atypical centromere associated with an inverted duplication of the region 14q32→qter. The marker chromosome’s reduced centromere lacks both the α and β satellite sequences usually found at normal centromeres. In an attempt to identify the centromeric sequences, the marker chromosome was flow-sorted and amplified by a degenerate oligonucleotide primer polymerase chain reaction. Reverse chromosome painting experiments showed that the marker chromosome contains sequences that are unique to the distal region of chromosome 14, as well as a low copy number of (centromeric) sequences that are also highly represented in the centromeres of chromosomes 18 and 19. These data suggest the activation of a novel centromere in the 14q32→qter region, very likely consequent to the duplication of the region itself.
4 September 2025 in Science
The anti-apoptotic protein MCL-1 (myeloid cell leukemia-1) is essential for embryogenesis and the survival of many cell types that tolerate loss of its relatives, BCL-XL and BCL-2. Apoptosis-unrelated roles of MCL-1 in metabolism may contribute to this requirement, although their relevance for embryogenesis and postnatal life remains unclear. We hypothesized that BCL-XL and BCL-2 may substitute MCL-1’s anti-apoptotic but not its apoptosis-unrelated functions. Replacing MCL-1 with BCL-XL or BCL-2 supported embryo development by rescuing the
Mcl-1
−/−
preimplantation lethality.
Mcl-1
Bcl-xL/Bcl-xL
but not
Mcl-1
Bcl-2/Bcl-2
mice were born on a mixed background, although they showed metabolic defects. Thus MCL-1’s apoptosis-unrelated functions appear critical in later development, with BCL-XL, but not BCL-2, partially compensating. These findings clarify MCL-1’s distinct physiological roles, critically informing MCL-1 inhibitor development as cancer therapeutics.
13 April 2022 in Cytometry Part A
25 August 2016 in Cytometry Part A